search
Back to results

Development and Validation of an Artificial Intelligence-based Biliary Stricture Navigation System in MRCP-based ERCP

Primary Purpose

Gastrointestinal Disease, Endoscopy, Artificial Intelligence

Status
Unknown status
Phase
Not Applicable
Locations
China
Study Type
Interventional
Intervention
Artificial intelligence assistant system
Sponsored by
Renmin Hospital of Wuhan University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Gastrointestinal Disease

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  1. Bile duct segmentation model 1) Male or female aged 18 or above; 2) Who needs ERCP,MRCP and its related tests are needed to further define the characteristics of digestive tract diseases; 3)The images of MRCP and ERCP are clear; 4) Able to read, understand and sign informed consent; 5) The investigator believes that the subject can understand the process of the clinical study and is willing and able to complete all the study procedures and follow-up visits and cooperate with the study procedures.
  2. Bile duct matching model

In addition to the criteria mentioned in the bile duct segmentation model, the bile duct matching model should also meet the following criteria:

  1. Able to complete MRCP in prone position;
  2. Bile ducts are almost completely visible in MRCP and ERCP.

(3) Clinical trials

In addition to the criteria mentioned in the bile duct segmentation model, the clinical trials should also meet the following criteria:

  1. Able to complete MRCP in prone position;
  2. Patients requiring biliary drainage by ERCP due to malignant hilar biliary obstruction.

Exclusion Criteria:

  1. Bile duct segmentation model and bile duct matching model 1)Has participated in other clinical trials, signed the informed consent and was in the follow-up period of other clinical trials; 2) Drug or alcohol abuse or psychological disorder in the last 5 years; 3) Patients in pregnancy or lactation; 4) The investigator considers that the subjects were not suitable for MRCP, ERCP and related tests; 5)A high-risk diseases or other special conditions that the investigator considers inappropriate for the subject to participate in a clinical trial;
  2. Clinical trials

In addition to the criteria mentioned in the above, the clinical trial must not meet any of the following criteria:

  1. Previous gastrectomy;
  2. Stent replacement;
  3. Pyloric or duodenal obstruction.

Sites / Locations

  • Renmin hospital of Wuhan UniversityRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

No Intervention

Arm Label

with AI navigation system

without AI navigation system

Arm Description

The endoscopists in the experimental group will be assisted by AI system, which can instruct the direction of guide wire and the position of stent placement in real time. The system is an non-invasive AI system.All patients underwent MRCP in the prone position prior to ERCP. A round box with a diameter of 2mm filled with water was pasted next to the patient's spine at the level of angulus inferior scapulae during MRCP, and a sheet metal with a diameter of 2mm was pasted at the same area during ERCP.

The endoscopists in the contrpl group performs ERCP routinely without special prompts.All patients underwent MRCP in the prone position prior to ERCP. A round box with a diameter of 2mm filled with water was pasted next to the patient's spine at the level of angulus inferior scapulae during MRCP, and a sheet metal with a diameter of 2mm was pasted at the same area during ERCP.

Outcomes

Primary Outcome Measures

Procedure time
The time of performing ERCP

Secondary Outcome Measures

Intersection over Union of bile duct segmentation
Intersection over Union of bile ducts predicted by artificial intelligence devices and actual bile ducts
Intersection over union of bile duct matching model:
Intersection over Union of the bile ducts generated by the AI device and the actual bile ducts in ERCP
Success rate of stent placement
The number of successful patients is the numerator, and the total number of patients with stent placement is the denominator.
Rate of adverse events
The number of patients who experienced adverse events was numerator, and the total number of patients undergoing stent placement was denominator.
Fluoroscopy time
The sum of the total X ray fluoroscopy time during the whole procedure.
Total amount of contrast medium
Total amount of contrast medium during the whole procedure.
The difference of the area of bile duct visualization in different position
The area of bile duct visualization of MRCP in different position
The difference in the time required to perform MRCP in different position
The difference in the time required to perform MRCP in different position

Full Information

First Posted
May 17, 2021
Last Updated
June 1, 2021
Sponsor
Renmin Hospital of Wuhan University
search

1. Study Identification

Unique Protocol Identification Number
NCT04903444
Brief Title
Development and Validation of an Artificial Intelligence-based Biliary Stricture Navigation System in MRCP-based ERCP
Official Title
A Single-center Study on the Effectiveness and Safety of Artificial Intelligence Assisted System in Clinical Application of Endoscopic Retrograde Cholangiopancreatography
Study Type
Interventional

2. Study Status

Record Verification Date
May 2021
Overall Recruitment Status
Unknown status
Study Start Date
May 27, 2021 (Actual)
Primary Completion Date
June 1, 2022 (Anticipated)
Study Completion Date
July 1, 2022 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Renmin Hospital of Wuhan University

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
In this study, the investigators proposed an artificial intelligence-based biliary stricture navigation system in MRCP-based ERCP, which can instruct the direction of guide wire and the position of stent placement in real time.
Detailed Description
585/5000 Biliary stricture can be divided into benign biliary stricture and malignant biliary stricture, and malignant hilar biliary obstruction is the one of the common cause. Since there is no specific early screening method for malignant hilar biliary obstruction at present and most patients have no obvious clinical symptoms in the early stage, most patients are already in the advanced stage when they are first diagnosed. Advanced malignant hilar biliary obstruction cannot undergo resection surgery, whose first choice for the treatment is palliative endoscopic biliary drainage.Biliary drainage can relieve jaundice, pruritus and other symptoms due to cholestasis. However,before the narrow segment was placed the stent, the contrast agent could not pass through the narrow segment and the bile duct above the narrow segment could not be seen.So it was difficult for doctors to determine the direction of the guide wire and the position of the stent. In addition, indiscriminate application of the contrast agent may cause outflow obstruction leading to infection. However, there is no relevant research to solve these problems. MRCP is the preferred examination method of pancreatic and bile duct diseases. Therefore, MRCP should be routinely performed before patients are treated with ERCP. At present, MRCP is in supine position, and ERCP is in prone position. Different positions lead to differences in the morphology of MRCP and the bile duct on ERCP.So preoperative MRCP in supine position has limited role in advising physicians on the morphology of the bile duct. Therefore, MRCP in the prone position is more favorable for endoscopists to perform ERCP . In recent years, deep learning algorithms have been continuously developed and increasingly mature.They have been gradually applied to the medical field. Computer vision is a science that studies how to make machines "see". Through deep learning, camera and computer can replace human eyes to carry out machine vision such as target recognition, tracking and measurement.Interdisciplinary cooperation in the field of medical imaging and computer vision is also one of the research hotspots in recent years. At present, it is mainly applied to the automatic identification and detection of lesions and quality control, and has achieved good results. It can assist doctors to find lesions, make disease diagnosis and standardize doctors' operations, so as to improve the quality of doctors' operations.With mature technical support, it has a good prospect and application value to develop endoscopic operating system for lesion detection and quality control based on artificial intelligence methods such as deep learning. In this study, the investigators proposed an artificial Intelligence-based Biliary Stricture Navigation System in MRCP-based ERCP, which can instruct the direction of guide wire and the position of stent placement in real time.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Gastrointestinal Disease, Endoscopy, Artificial Intelligence, Endoscopic Retrograde Cholangiopancreatography

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantOutcomes Assessor
Allocation
Randomized
Enrollment
62 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
with AI navigation system
Arm Type
Experimental
Arm Description
The endoscopists in the experimental group will be assisted by AI system, which can instruct the direction of guide wire and the position of stent placement in real time. The system is an non-invasive AI system.All patients underwent MRCP in the prone position prior to ERCP. A round box with a diameter of 2mm filled with water was pasted next to the patient's spine at the level of angulus inferior scapulae during MRCP, and a sheet metal with a diameter of 2mm was pasted at the same area during ERCP.
Arm Title
without AI navigation system
Arm Type
No Intervention
Arm Description
The endoscopists in the contrpl group performs ERCP routinely without special prompts.All patients underwent MRCP in the prone position prior to ERCP. A round box with a diameter of 2mm filled with water was pasted next to the patient's spine at the level of angulus inferior scapulae during MRCP, and a sheet metal with a diameter of 2mm was pasted at the same area during ERCP.
Intervention Type
Device
Intervention Name(s)
Artificial intelligence assistant system
Intervention Description
The endoscopists in the experimental group will be assisted by AI system, which can instruct the direction of guide wire and the position of stent placement in real time. The system is an non-invasive AI system .
Primary Outcome Measure Information:
Title
Procedure time
Description
The time of performing ERCP
Time Frame
During procedure
Secondary Outcome Measure Information:
Title
Intersection over Union of bile duct segmentation
Description
Intersection over Union of bile ducts predicted by artificial intelligence devices and actual bile ducts
Time Frame
A month
Title
Intersection over union of bile duct matching model:
Description
Intersection over Union of the bile ducts generated by the AI device and the actual bile ducts in ERCP
Time Frame
6 month
Title
Success rate of stent placement
Description
The number of successful patients is the numerator, and the total number of patients with stent placement is the denominator.
Time Frame
During procedure
Title
Rate of adverse events
Description
The number of patients who experienced adverse events was numerator, and the total number of patients undergoing stent placement was denominator.
Time Frame
Until discharge assessed up to 14 days
Title
Fluoroscopy time
Description
The sum of the total X ray fluoroscopy time during the whole procedure.
Time Frame
During procedure
Title
Total amount of contrast medium
Description
Total amount of contrast medium during the whole procedure.
Time Frame
During procedure
Title
The difference of the area of bile duct visualization in different position
Description
The area of bile duct visualization of MRCP in different position
Time Frame
During procedure
Title
The difference in the time required to perform MRCP in different position
Description
The difference in the time required to perform MRCP in different position
Time Frame
During procedure

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Bile duct segmentation model 1) Male or female aged 18 or above; 2) Who needs ERCP,MRCP and its related tests are needed to further define the characteristics of digestive tract diseases; 3)The images of MRCP and ERCP are clear; 4) Able to read, understand and sign informed consent; 5) The investigator believes that the subject can understand the process of the clinical study and is willing and able to complete all the study procedures and follow-up visits and cooperate with the study procedures. Bile duct matching model In addition to the criteria mentioned in the bile duct segmentation model, the bile duct matching model should also meet the following criteria: Able to complete MRCP in prone position; Bile ducts are almost completely visible in MRCP and ERCP. (3) Clinical trials In addition to the criteria mentioned in the bile duct segmentation model, the clinical trials should also meet the following criteria: Able to complete MRCP in prone position; Patients requiring biliary drainage by ERCP due to malignant hilar biliary obstruction. Exclusion Criteria: Bile duct segmentation model and bile duct matching model 1)Has participated in other clinical trials, signed the informed consent and was in the follow-up period of other clinical trials; 2) Drug or alcohol abuse or psychological disorder in the last 5 years; 3) Patients in pregnancy or lactation; 4) The investigator considers that the subjects were not suitable for MRCP, ERCP and related tests; 5)A high-risk diseases or other special conditions that the investigator considers inappropriate for the subject to participate in a clinical trial; Clinical trials In addition to the criteria mentioned in the above, the clinical trial must not meet any of the following criteria: Previous gastrectomy; Stent replacement; Pyloric or duodenal obstruction.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Honggang Yu, Doctor
Phone
+862788041911
Email
whdxrmyy@126.com
First Name & Middle Initial & Last Name or Official Title & Degree
Honggang Yu Yu, Doctor
Phone
+862788041911
Email
whdxrmyy@126.com
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Honggang Yu Yu, Doctor
Organizational Affiliation
Renmin Hospital of Wuhan University
Official's Role
Principal Investigator
Facility Information:
Facility Name
Renmin hospital of Wuhan University
City
Wuhan
State/Province
Hubei
ZIP/Postal Code
430000
Country
China
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Honggang Yu, Doctor
Phone
+862788041911
Email
whdxrmyy@126.com

12. IPD Sharing Statement

Learn more about this trial

Development and Validation of an Artificial Intelligence-based Biliary Stricture Navigation System in MRCP-based ERCP

We'll reach out to this number within 24 hrs